GO
Loading...

Enter multiple symbols separated by commas

Biotech and Pharmaceuticals

More

  • Drug-resistant intestinal illness spreading in US Thursday, 2 Apr 2015 | 1:00 PM ET
    Shigella virus.

    An intestinal illness called Shigellosis and carried by international travelers is spreading across the U.S., according to the Centers for Disease Control and Prevention.

  • World Autism Awareness day Thursday, 2 Apr 2015 | 10:53 AM ET
    World Autism Awareness day

    CNBC's Meg Tirrell takes a deeper look at Autism, the people it affects and where treatment stands.

  • We're diversified and robust: Merrimack CEO Wednesday, 1 Apr 2015 | 2:05 PM ET
    We're diversified and robust: Merrimack CEO

    Merrimack CEO Bob Mulroy joins CNBC's Meg Tirrell to discuss the Merrimack development pipeline for nanotherapeutic chemotherapy.

  • Year's hottest headed for trouble? Wednesday, 1 Apr 2015 | 12:32 PM ET
    Year's hottest headed for trouble?

    Sam Isaly, OrbiMed Advisors managing partner, says valuations are more than they used to be but adds, they're not crazy, they're sensible. He shares his view of the biotech sector.

  • Biotech's next buzz: Gene therapy? Tuesday, 31 Mar 2015 | 11:51 AM ET
    A researcher tests gene therapy in Point Richmond, California.

    As gene therapy emerges in the biotech industry, one analyst explains why it could be the next billion dollar industry.

  • Is there a biotech bubble? Monday, 30 Mar 2015 | 6:38 PM ET
    Is there a biotech bubble?

    Andrew Morey, portfolio manager at ASTON LMCG Small Cap Growth Fund, attributes the rally in U.S. biotech shares to "fundamental merits" like clinical advances.

  • US pharmacist group moves to block execution drugs Monday, 30 Mar 2015 | 6:44 PM ET
    Hypodermic needle filled from vial

    A national pharmacists' group has adopted a policy discouraging its members from providing death-penalty drugs.

  • UnitedHealth's $12.8B deal Monday, 30 Mar 2015 | 2:03 PM ET
    UnitedHealth's $12.8B deal

    CNBC's Meg Tirrell reports on health care consolidation and PBM stocks to watch.

  • Catamaran leads Nasdaq Monday, 30 Mar 2015 | 1:00 PM ET
    Catamaran leads Nasdaq

    CNBC's Bertha Coombs reports on healthcare stock deals including Catamaran to be acquired by UnitedHealth for $12.8B.

  • Dinan's stocks: KRFT, SJM & MCD Monday, 30 Mar 2015 | 12:27 PM ET
    Dinan's stocks: KRFT, SJM & MCD

    Jamie Dinan, York Capital founder and CEO, discusses some of his firm's top stock picks. Among the names, he likes the Kraft Foods Group-Heinz deal, as well as McDonald's, which he says is now in the "show me" category.

  • Dinan: Shorting IBB can be dangerous Monday, 30 Mar 2015 | 12:25 PM ET
    Dinan: Shorting IBB can be dangerous

    Jamie Dinan, York Capital founder and CEO, discusses the advancements in biotechnology, and high stock valuations. He says shorting the biotech ETF can be dangerous.

  • Teva to buy Auspex for $3.2 billion in cash Monday, 30 Mar 2015 | 7:01 AM ET
    Teva to buy Auspex for $3.2 billion in cash

    Teva Pharmaceutical is buying Auspex Pharmaceuticals, reports CNBC's Joe Kernen.

  • Will the biotech run resume? Friday, 27 Mar 2015 | 12:00 AM ET
    Will the biotech run resume?

    After a tough week for biotech stocks, David Seaburg of Cowen & Co. and Craig Johnson of Piper Jaffray call the next move.

  • Genfit sinks 31%, but CEO defends liver drug results Friday, 27 Mar 2015 | 3:30 PM ET
    A researcher works in a laboratory of French biopharmaceutical company Genfit, in Loos, northern France, Nov. 15, 2012.

    The CEO of biotech company Genfit told CNBC that the markets are overreacting to the results of its NASH study.

  • Drug trial setbacks Friday, 27 Mar 2015 | 2:20 PM ET
    Drug trial setbacks

    After speaking with the Genfit CEO, CNBC's Meg Tirrell discusses the company's future and the potential opportunity.

  • Biotech woes: Deja vu all over again Thursday, 26 Mar 2015 | 12:59 PM ET
    Biotech

    For biotech watchers, it's deja vu all over again. Through Wednesday, the Nasdaq Biotechnology Index dropped 6.9 percent since the close March 20.

  • Biotech outlook dire as bull market loses leader Thursday, 26 Mar 2015 | 8:10 AM ET
    Biotech research

    Investors are bailing on biotech stocks at such a rapid pace that it is shocking even some of the most-seasoned traders.

  • Biotech's a little 'over its skis' but healthy: Analyst Thursday, 26 Mar 2015 | 7:46 AM ET
    Biotech a little 'over its skis' but healthy: Analyst

    Eric Schmidt, Cowen & Company analyst, provides perspective on the biotech space after the Nasdaq biotech index posted its worst daily drop since December.

  • Drugs companies unite to mine genetic data Thursday, 26 Mar 2015 | 2:25 AM ET

    Major pharmaceuticals companies have formed a partnership with Genomics England in the first step towards using genetic data from NHS patients.

  • Trading the selloff: 8 stocks to buy Wednesday, 25 Mar 2015 | 6:50 PM ET
    A file photo of a FedEx truck

    "Fast Money" traders discussed how to play Wednesday's selloff in biotech, transportation and technology names.

Contact Biotech and Pharma

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

 

  • Dan Mangan is a reporter covering health care for CNBC.com.

  • Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.

  • Bertha Coombs

    Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.